EPID:L-2021-LLA-0181
From kanterella
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
EPID - L-2021-LLA-0181, Response to the Request for Additional Information Proposed Technical Specifications 3.4.12 and 3.4.13 Revised Dose Calculations (Approved, Closed) 30 September 2021 - 9 December 2022 | |
|---|---|
Request for: - License Amendment Approved, Closed | |
Initiation
| |
MONTHYEAR1CAN092101, License Amendment Request Proposed Technical Specifications 3.4.12 and 3.4.13 Revised Dose Calculations2021-09-30030 September 2021
[table view]Title: License Amendment Request Proposed Technical Specifications 3.4.12 and 3.4.13 Revised Dose Calculations ML21320A2122021-11-17017 November 2021 Title: Supplemental Information Needed for Acceptance of Requested Licensing Action License Amendment Request Concerning Revised Dose Calculations 1CAN122101, Response to Request for Supplemental Information Concerning Licensing Amendment Request to Revise Technical Specification 3.4.12 and 3.4.132021-12-0202 December 2021 Title: Response to Request for Supplemental Information Concerning Licensing Amendment Request to Revise Technical Specification 3.4.12 and 3.4.13 ML21341B2262021-12-13013 December 2021 Title: Acceptance of Requested Licensing Action License Amendment Request to Revise Technical Specifications 3.4.12 and 3.4.13 Based on Revised Dose Calculations ML22019A1342022-01-21021 January 2022 Title: Audit Plan to Support Review of License Amendment Request for Technical Specification Changes Due to Revised Dose Calculations ML22108A1642022-04-18018 April 2022 Title: NRR E-mail Capture - ANO-1: Final RAI License Amendment Request Concerning TS Changes Due to Revised Dose Calculations (L-2021-LLA-0181) 1CAN062201, Response to the Request for Additional Information Proposed Technical Specifications 3.4.12 and 3.4.13 Revised Dose Calculations2022-06-0202 June 2022 Title: Response to the Request for Additional Information Proposed Technical Specifications 3.4.12 and 3.4.13 Revised Dose Calculations ML22174A3342022-07-12012 July 2022 Title: Regulatory Audit Summary Concerning License Amendment Request for Technical Specification Changes Due to Revised Dose Calculations ML22181A0582022-07-15015 July 2022 Title: Request for Withholding Information from Public Disclosure 1CAN102201, Supplement to Proposed Technical Specifications 3.4.12 and 3.4.13 Revised Dose Calculations2022-10-13013 October 2022 Title: Supplement to Proposed Technical Specifications 3.4.12 and 3.4.13 Revised Dose Calculations ML22291A2402022-10-28028 October 2022 Title: Notice of Consideration of Issuance of Amendment to Renewed Facility Operating License, Proposed Nshcd, and Opportunity for a Hearing and Order Imposing Procedures for Document Access to SUNSI (EPID L-2021-LLA-0181) (FRN) ML22291A2552022-10-28028 October 2022 Title: Notice of Consideration of Issuance of Amendment to Renewed Facility Operating License, Proposed Nshcd, and Opportunity for a Hearing and Order Imposing Procedures for Document Access to SUNSI ML22291A2392022-10-28028 October 2022 Title: Notice of Consideration of Issuance of Amendment to Renewed Facility Operating License, Proposed Nshcd, and Opportunity for a Hearing and Order Imposing Procedures for Document Access to SUNSI (EPID L-2021-LLA-0181) Letter ML22305A5632022-11-28028 November 2022 Title: Request for Withholding Information from Public Disclosure ML22263A1912022-12-0909 December 2022 Title: Issuance of Amendment No. 278 Revision to Technical Specifications 3.4.12 and 3.4.13 Based on Revised Dose Calculations (EPID L-2021-LLA-0181) - Non-Proprietary 2022-10-28 |